Janone (ALTS) Competitors $6.64 -0.15 (-2.21%) Closing price 04:00 PM EasternExtended Trading$6.64 0.00 (0.00%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock ALTS vs. SIGA, SAGE, MGTX, RGNX, PRTA, PRTC, SANA, AMLX, ORGO, and TRMLShould you be buying Janone stock or one of its competitors? The main competitors of Janone include SIGA Technologies (SIGA), Sage Therapeutics (SAGE), MeiraGTx (MGTX), REGENXBIO (RGNX), Prothena (PRTA), PureTech Health (PRTC), Sana Biotechnology (SANA), Amylyx Pharmaceuticals (AMLX), Organogenesis (ORGO), and Tourmaline Bio (TRML). These companies are all part of the "pharmaceutical products" industry. Janone vs. SIGA Technologies Sage Therapeutics MeiraGTx REGENXBIO Prothena PureTech Health Sana Biotechnology Amylyx Pharmaceuticals Organogenesis Tourmaline Bio SIGA Technologies (NASDAQ:SIGA) and Janone (NASDAQ:ALTS) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, valuation, institutional ownership, dividends, media sentiment, profitability, earnings and risk. Do insiders & institutionals have more ownership in SIGA or ALTS? 55.4% of SIGA Technologies shares are held by institutional investors. Comparatively, 6.3% of Janone shares are held by institutional investors. 1.5% of SIGA Technologies shares are held by insiders. Comparatively, 4.9% of Janone shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has more volatility & risk, SIGA or ALTS? SIGA Technologies has a beta of 0.92, meaning that its stock price is 8% less volatile than the S&P 500. Comparatively, Janone has a beta of 2.14, meaning that its stock price is 114% more volatile than the S&P 500. Does the media prefer SIGA or ALTS? In the previous week, SIGA Technologies had 4 more articles in the media than Janone. MarketBeat recorded 5 mentions for SIGA Technologies and 1 mentions for Janone. SIGA Technologies' average media sentiment score of 0.72 beat Janone's score of 0.58 indicating that SIGA Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SIGA Technologies 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Janone 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is SIGA or ALTS more profitable? SIGA Technologies has a net margin of 49.33% compared to Janone's net margin of 0.00%. SIGA Technologies' return on equity of 49.06% beat Janone's return on equity.Company Net Margins Return on Equity Return on Assets SIGA Technologies49.33% 49.06% 38.72% Janone N/A -2,940.01%-39.81% Which has stronger valuation and earnings, SIGA or ALTS? SIGA Technologies has higher revenue and earnings than Janone. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSIGA Technologies$120.33M3.64$68.07M$0.679.15Janone$12.53M9.25-$7.81MN/AN/A Does the MarketBeat Community prefer SIGA or ALTS? SIGA Technologies received 5 more outperform votes than Janone when rated by MarketBeat users. CompanyUnderperformOutperformSIGA TechnologiesOutperform Votes523.81% Underperform Votes1676.19% JanoneN/AN/A SummarySIGA Technologies beats Janone on 9 of the 12 factors compared between the two stocks. Get Janone News Delivered to You Automatically Sign up to receive the latest news and ratings for ALTS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALTS vs. The Competition Export to ExcelMetricJanonePharmaceutical IndustryFinance SectorNASDAQ ExchangeMarket Cap$115.90M$6.48B$11.49B$8.38BDividend YieldN/A2.66%5.46%4.10%P/E RatioN/A8.9222.4819.71Price / Sales9.25250.9527.28116.98Price / CashN/A65.8517.6234.62Price / Book-9.916.462.794.50Net Income-$7.81M$143.98M$1.04B$248.18M7 Day Performance7.62%3.04%0.34%1.14%1 Month Performance19.42%7.44%8.69%15.20%1 Year PerformanceN/A-2.46%537.74%6.56% Janone Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALTSJanoneN/A$6.64-2.2%N/AN/A$115.90M$12.53M0.00170News CoverageSIGASIGA Technologies1.3585 of 5 stars$5.94flatN/A-17.9%$424.36M$138.72M4.9540SAGESage Therapeutics3.955 of 5 stars$6.61-2.1%$8.81+33.3%-36.2%$413.93M$47.40M-1.00690Analyst DowngradeMGTXMeiraGTx4.5792 of 5 stars$5.15-8.4%$24.50+375.7%-0.7%$411.75M$33.28M-4.26300Analyst RevisionHigh Trading VolumeRGNXREGENXBIO4.272 of 5 stars$8.18+2.6%$31.63+286.6%-37.0%$409.96M$83.33M-1.63370Analyst RevisionHigh Trading VolumePRTAProthena3.8653 of 5 stars$7.59-0.3%$51.71+581.3%-67.8%$408.55M$137.94M-3.30130Positive NewsHigh Trading VolumePRTCPureTech Health1.5174 of 5 stars$17.00+1.6%$45.00+164.7%-39.3%$408.32M$4.32M0.00100Gap UpSANASana Biotechnology2.4474 of 5 stars$1.80-10.3%$10.80+501.7%-75.8%$404.73MN/A-1.28380Gap UpAMLXAmylyx Pharmaceuticals3.4725 of 5 stars$4.49-2.4%$9.67+115.3%+200.0%$399.99M$-1,272,000.00-1.18200ORGOOrganogenesis4.0395 of 5 stars$3.15+5.4%$5.50+74.6%+17.7%$399.59M$458.76M-52.50950News CoverageHigh Trading VolumeTRMLTourmaline Bio1.8568 of 5 stars$15.54-1.5%$49.33+217.5%+11.3%$399.15MN/A-5.5144News Coverage Related Companies and Tools Related Companies SIGA Alternatives SAGE Alternatives MGTX Alternatives RGNX Alternatives PRTA Alternatives PRTC Alternatives SANA Alternatives AMLX Alternatives ORGO Alternatives TRML Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALTS) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Janone Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Janone With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ALTS Stock Free ALTS Stock Alerts